BusinessCell Design Labs Appoints Roger Sidhu, M.D. as Chief Medical OfficerBy Nasdaq OMXAug 1, 2017, 12:00 PM UTC
BusinessLentigen Technology Inc., a Miltenyi Biotec Company, Acquires University of Maryland, Baltimore CAR-T Cell Start-Up, Living Pharma, Inc.By Nasdaq OMXJul 20, 2017, 12:00 PM UTC
BusinessGE Ventures, Mayo Clinic Ventures and DFJ Invest $13.75M in First Software Platform to Accelerate Cancer Cure Process and DeliveryBy Nasdaq OMXJun 20, 2017, 11:30 AM UTC
BusinessCell Design Labs Announces Issuance of Broad Patent for Chimeric Notch (synNotch™) Receptor to Treat Cancer and Other DiseasesBy Nasdaq OMXJun 7, 2017, 12:00 PM UTC
BusinessTeneobio and Poseida Announce License Agreement for the Use of UniDab™ in CAR T-Cell TherapyBy Nasdaq OMXMay 22, 2017, 12:02 PM UTC
BusinessTeneobio and Poseida Announce License Agreement for the Use of UniDab™ in CAR T-Cell TherapyBy Nasdaq OMXMay 22, 2017, 12:02 PM UTC
BusinessCellular Biomedicine Group (CBMG) Announces Publication Titled “Target cell killing effects of CD20 targeting chimeric antigen receptor T cells derived from the type II anti-CD20 antibody” in Conjunction with 2017 ASCO Annual MeetingBy Nasdaq OMXMay 19, 2017, 12:29 PM UTC
BusinessCellular Biomedicine Group (CBMG) Announces Publication Titled “Target cell killing effects of CD20 targeting chimeric antigen receptor T cells derived from the type II anti-CD20 antibody” in Conjunction with 2017 ASCO Annual MeetingBy Nasdaq OMXMay 19, 2017, 12:29 PM UTC
